ACQUIRED · 2021
Who Acquired RxBenefits?
Advent International · $1.10B· 18.3× EBITDA
The acquisition
RxBenefits was acquired by Advent International in 2021 for $1.10B. The deal was priced at 18.3× EBITDA / 7.90× revenue.
RxBenefits at time of acquisition
Revenue
$140.0M
EBITDA
$60.0M
Deal value
$1.10B
EV / EBITDA
18.3×
Other acquisitions by Advent International
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- PatientPoint · 2025 · $1.40B · 31.1× EBITDA
Similar healthcare it acquisitions
- Eucalyptus · acquired by Hims & Hers Health, Inc. in 2026 · $1.15B
- Gleamer SAS · acquired by RadNet, Inc. in 2026 · $251.6M
- HealthEZ · acquired by Blue Cross Blue Shield of New Jersey in 2026 · $360.0M
- Unbound Medicine · acquired by MPS Ltd in 2026 · $16.5M
- AccessOne · acquired by Phreesia, Inc. in 2025 · $160.0M
Run a valuation for a similar healthcare it business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the healthcare it calculator →More on healthcare it valuations
- Healthcare It valuation calculator· head-term variant
- Healthcare It median multiples· real-deal benchmarks
- How to value a healthcare it· long-form guide
Sourced from Press releases, press reporting, and bond market research. Full deal page.
Citation: ExitValue.ai. (2021). RxBenefits acquired by Advent International. https://exitvalue.ai/acquired/rxbenefits